TIFFANY JOHNSON: Open Payments
NPI 1235389107 · PASADENA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$909 in 32 payments from 13 companies in 2025. Trend: 2023 $1,107 · 2024 $658 · 2025 $909
Food & beverage: $829Education: $80
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $154 |
| Hologic Sales and Service, LLC | 3 | $140 |
| Actelion Pharmaceuticals US, Inc. | 4 | $113 |
| Astellas Pharma US Inc | 2 | $105 |
| Novartis Pharmaceuticals Corporation | 3 | $79 |
| ABBVIE INC. | 4 | $75 |
| United Therapeutics Corporation | 3 | $74 |
| Insmed, Inc. | 2 | $52 |
| Baxter Healthcare | 2 | $35 |
| Grifols USA, LLC | 1 | $25 |
Products named: FLUENT FLUID MANAGEMENT SYSTEM, OFEV, OPSUMIT, LEQVIO, Tyvaso, JASCAYD, Arikayce, TEFLARO.
Industry payments across TX — which companies pay providers there.
